Use of nitroxides for the treatment of essential hypertension
US6617337B1 · kind B1 · utility
29Cited by
17References
22Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 5, 2001 |
| Grant date | Sep 9, 2003 |
| Priority date | — |
| Expiry date | Jan 5, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P9/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention encompasses methods of treating patients for essential hypertension. The invention also includes related pharmaceutical compositions of nitroxides. Specific drugs, such as 4-hydroxy-2,2,6,6-tetramethyl-1-piperidinyloxy (Tempol) are disclosed. These compositions are also contemplated for use in the treatment of oxidative stress and modulation of blood pressure.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.